1. Home
  2. MMED vs APGE Comparison

MMED vs APGE Comparison

Compare MMED & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MMED

MiniMed Group Inc. Common Stock

N/A

Current Price

$16.97

Market Cap

4.3B

Sector

Health Care

ML Signal

N/A

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

HOLD

Current Price

$134.18

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MMED
APGE
Founded
1983
2022
Country
United States
United States
Employees
2800
N/A
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
4.7B
IPO Year
2026
2023

Fundamental Metrics

Financial Performance
Metric
MMED
APGE
Price
$16.97
$134.18
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
13
Target Price
$22.56
$109.67
AVG Volume (30 Days)
1.1M
5.4M
Earning Date
06-03-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$15.99
N/A
Revenue Next Year
$10.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.65
$34.34
52 Week High
$17.86
$134.32

Technical Indicators

Market Signals
Indicator
MMED
APGE
Relative Strength Index (RSI) 67.21 80.78
Support Level $14.70 $80.52
Resistance Level N/A N/A
Average True Range (ATR) 0.88 0.42
MACD 0.11 -1.53
Stochastic Oscillator 88.11 91.02

Price Performance

Historical Comparison
MMED
APGE

About MMED MiniMed Group Inc. Common Stock

Minimed Group Inc is a scaled medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. It serves PWD who require intensive insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform of simple and clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and Smart Multiple Daily Injection (MDI) Systems. It derives revenue from the sale of products focused on diabetes management, including insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens. Geographically, it operates in the USA and the Rest of World, with the majority of revenue derived from the Rest of World.

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Share on Social Networks: